Prognosis factors and risk-adapted therapy of Hodgkin lymphoma
10.3760/cma.j.cn115356-20190813-00154
- VernacularTitle:霍奇金淋巴瘤预后因素与风险适应性治疗
- Author:
Bian WEI
1
;
Huaqing WANG
;
Zhi CHANG
;
Yang ZHENG
Author Information
1. 天津市人民医院肿瘤诊治中心 天津市中西医结合肿瘤研究所 300121
- From:
Journal of Leukemia & Lymphoma
2020;29(7):385-388
- CountryChina
- Language:Chinese
-
Abstract:
Hodgkin lymphoma (HL) is a kind of malignant lymphoma with a good prognosis. With the constant development of medical technology, the cure rate of HL has increased significantly. At present, the main problem is risk-adapted therapy according to the disease condition and prognosis-related factors to increase or decrease the intensity of treatment, in order to increase the cure rate and reduce the side effects, prolong the survival time and improve the quality of life of patients. This article focuses on the analysis of HL prognosis-related factors, common treatment methods for HL, and the effect of PET-CT results on the implementation of risk-adapted therapy.
